Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
45,497
archived clinical trials in
Breast Cancer

TAC Versus TC for Adjuvant Breast Cancer
Phase III Trial of TC Versus TAC in HER2-Negative Early Stage Breast Cancer Patients
Status: Enrolling
Updated:  12/31/1969
1221
mi
from 91732
Dallas, TX
TAC Versus TC for Adjuvant Breast Cancer
Phase III Trial of TC Versus TAC in HER2-Negative Early Stage Breast Cancer Patients
Status: Enrolling
Updated: 12/31/1969
Methodist Charlton Cancer Ctr.
1221
mi
from 91732
Dallas, TX
Click here to add this to my saved trials
TAC Versus TC for Adjuvant Breast Cancer
Phase III Trial of TC Versus TAC in HER2-Negative Early Stage Breast Cancer Patients
Status: Enrolling
Updated:  12/31/1969
1203
mi
from 91732
Denton, TX
TAC Versus TC for Adjuvant Breast Cancer
Phase III Trial of TC Versus TAC in HER2-Negative Early Stage Breast Cancer Patients
Status: Enrolling
Updated: 12/31/1969
Texas Cancer Center
1203
mi
from 91732
Denton, TX
Click here to add this to my saved trials
TAC Versus TC for Adjuvant Breast Cancer
Phase III Trial of TC Versus TAC in HER2-Negative Early Stage Breast Cancer Patients
Status: Enrolling
Updated:  12/31/1969
693
mi
from 91732
El Paso, TX
TAC Versus TC for Adjuvant Breast Cancer
Phase III Trial of TC Versus TAC in HER2-Negative Early Stage Breast Cancer Patients
Status: Enrolling
Updated: 12/31/1969
El Paso Cancer Treatment Center
693
mi
from 91732
El Paso, TX
Click here to add this to my saved trials
TAC Versus TC for Adjuvant Breast Cancer
Phase III Trial of TC Versus TAC in HER2-Negative Early Stage Breast Cancer Patients
Status: Enrolling
Updated:  12/31/1969
mi
from 91732
Fort Worth, TX
TAC Versus TC for Adjuvant Breast Cancer
Phase III Trial of TC Versus TAC in HER2-Negative Early Stage Breast Cancer Patients
Status: Enrolling
Updated: 12/31/1969
Texas Oncology P.A.
mi
from 91732
Fort Worth, TX
Click here to add this to my saved trials
TAC Versus TC for Adjuvant Breast Cancer
Phase III Trial of TC Versus TAC in HER2-Negative Early Stage Breast Cancer Patients
Status: Enrolling
Updated:  12/31/1969
1229
mi
from 91732
Garland, TX
TAC Versus TC for Adjuvant Breast Cancer
Phase III Trial of TC Versus TAC in HER2-Negative Early Stage Breast Cancer Patients
Status: Enrolling
Updated: 12/31/1969
Texas Oncology PA
1229
mi
from 91732
Garland, TX
Click here to add this to my saved trials
TAC Versus TC for Adjuvant Breast Cancer
Phase III Trial of TC Versus TAC in HER2-Negative Early Stage Breast Cancer Patients
Status: Enrolling
Updated:  12/31/1969
1349
mi
from 91732
Houston, TX
TAC Versus TC for Adjuvant Breast Cancer
Phase III Trial of TC Versus TAC in HER2-Negative Early Stage Breast Cancer Patients
Status: Enrolling
Updated: 12/31/1969
Texas Oncology
1349
mi
from 91732
Houston, TX
Click here to add this to my saved trials
TAC Versus TC for Adjuvant Breast Cancer
Phase III Trial of TC Versus TAC in HER2-Negative Early Stage Breast Cancer Patients
Status: Enrolling
Updated:  12/31/1969
1209
mi
from 91732
Lewisville, TX
TAC Versus TC for Adjuvant Breast Cancer
Phase III Trial of TC Versus TAC in HER2-Negative Early Stage Breast Cancer Patients
Status: Enrolling
Updated: 12/31/1969
Lake Vista Cancer Center
1209
mi
from 91732
Lewisville, TX
Click here to add this to my saved trials
TAC Versus TC for Adjuvant Breast Cancer
Phase III Trial of TC Versus TAC in HER2-Negative Early Stage Breast Cancer Patients
Status: Enrolling
Updated:  12/31/1969
1346
mi
from 91732
Longview, TX
TAC Versus TC for Adjuvant Breast Cancer
Phase III Trial of TC Versus TAC in HER2-Negative Early Stage Breast Cancer Patients
Status: Enrolling
Updated: 12/31/1969
Longview Cancer Center
1346
mi
from 91732
Longview, TX
Click here to add this to my saved trials
TAC Versus TC for Adjuvant Breast Cancer
Phase III Trial of TC Versus TAC in HER2-Negative Early Stage Breast Cancer Patients
Status: Enrolling
Updated:  12/31/1969
1298
mi
from 91732
McAllen, TX
TAC Versus TC for Adjuvant Breast Cancer
Phase III Trial of TC Versus TAC in HER2-Negative Early Stage Breast Cancer Patients
Status: Enrolling
Updated: 12/31/1969
South Texas Cancer Center - McAllen
1298
mi
from 91732
McAllen, TX
Click here to add this to my saved trials
TAC Versus TC for Adjuvant Breast Cancer
Phase III Trial of TC Versus TAC in HER2-Negative Early Stage Breast Cancer Patients
Status: Enrolling
Updated:  12/31/1969
1233
mi
from 91732
Mesquite, TX
TAC Versus TC for Adjuvant Breast Cancer
Phase III Trial of TC Versus TAC in HER2-Negative Early Stage Breast Cancer Patients
Status: Enrolling
Updated: 12/31/1969
Texas Cancer Center of Mesquite
1233
mi
from 91732
Mesquite, TX
Click here to add this to my saved trials
TAC Versus TC for Adjuvant Breast Cancer
Phase III Trial of TC Versus TAC in HER2-Negative Early Stage Breast Cancer Patients
Status: Enrolling
Updated:  12/31/1969
932
mi
from 91732
Midland, TX
TAC Versus TC for Adjuvant Breast Cancer
Phase III Trial of TC Versus TAC in HER2-Negative Early Stage Breast Cancer Patients
Status: Enrolling
Updated: 12/31/1969
Allison Cancer Center
932
mi
from 91732
Midland, TX
Click here to add this to my saved trials
TAC Versus TC for Adjuvant Breast Cancer
Phase III Trial of TC Versus TAC in HER2-Negative Early Stage Breast Cancer Patients
Status: Enrolling
Updated:  12/31/1969
919
mi
from 91732
Odessa, TX
TAC Versus TC for Adjuvant Breast Cancer
Phase III Trial of TC Versus TAC in HER2-Negative Early Stage Breast Cancer Patients
Status: Enrolling
Updated: 12/31/1969
Texas Oncology - Odessa
919
mi
from 91732
Odessa, TX
Click here to add this to my saved trials
TAC Versus TC for Adjuvant Breast Cancer
Phase III Trial of TC Versus TAC in HER2-Negative Early Stage Breast Cancer Patients
Status: Enrolling
Updated:  12/31/1969
1285
mi
from 91732
Paris, TX
TAC Versus TC for Adjuvant Breast Cancer
Phase III Trial of TC Versus TAC in HER2-Negative Early Stage Breast Cancer Patients
Status: Enrolling
Updated: 12/31/1969
Paris Regional Cancer Center
1285
mi
from 91732
Paris, TX
Click here to add this to my saved trials
TAC Versus TC for Adjuvant Breast Cancer
Phase III Trial of TC Versus TAC in HER2-Negative Early Stage Breast Cancer Patients
Status: Enrolling
Updated:  12/31/1969
1182
mi
from 91732
San Antonio, TX
TAC Versus TC for Adjuvant Breast Cancer
Phase III Trial of TC Versus TAC in HER2-Negative Early Stage Breast Cancer Patients
Status: Enrolling
Updated: 12/31/1969
South Texas Oncology and Hematology
1182
mi
from 91732
San Antonio, TX
Click here to add this to my saved trials
TAC Versus TC for Adjuvant Breast Cancer
Phase III Trial of TC Versus TAC in HER2-Negative Early Stage Breast Cancer Patients
Status: Enrolling
Updated:  12/31/1969
1188
mi
from 91732
San Antonio, TX
TAC Versus TC for Adjuvant Breast Cancer
Phase III Trial of TC Versus TAC in HER2-Negative Early Stage Breast Cancer Patients
Status: Enrolling
Updated: 12/31/1969
San Antonio Tumor and Blood Clinic
1188
mi
from 91732
San Antonio, TX
Click here to add this to my saved trials
TAC Versus TC for Adjuvant Breast Cancer
Phase III Trial of TC Versus TAC in HER2-Negative Early Stage Breast Cancer Patients
Status: Enrolling
Updated:  12/31/1969
1188
mi
from 91732
San Antonio, TX
TAC Versus TC for Adjuvant Breast Cancer
Phase III Trial of TC Versus TAC in HER2-Negative Early Stage Breast Cancer Patients
Status: Enrolling
Updated: 12/31/1969
HOAST-Medical Dr.
1188
mi
from 91732
San Antonio, TX
Click here to add this to my saved trials
TAC Versus TC for Adjuvant Breast Cancer
Phase III Trial of TC Versus TAC in HER2-Negative Early Stage Breast Cancer Patients
Status: Enrolling
Updated:  12/31/1969
1227
mi
from 91732
Sherman, TX
TAC Versus TC for Adjuvant Breast Cancer
Phase III Trial of TC Versus TAC in HER2-Negative Early Stage Breast Cancer Patients
Status: Enrolling
Updated: 12/31/1969
Texas Cancer Center - Sherman
1227
mi
from 91732
Sherman, TX
Click here to add this to my saved trials
TAC Versus TC for Adjuvant Breast Cancer
Phase III Trial of TC Versus TAC in HER2-Negative Early Stage Breast Cancer Patients
Status: Enrolling
Updated:  12/31/1969
1347
mi
from 91732
Sugar Land, TX
TAC Versus TC for Adjuvant Breast Cancer
Phase III Trial of TC Versus TAC in HER2-Negative Early Stage Breast Cancer Patients
Status: Enrolling
Updated: 12/31/1969
Texas Oncology Cancer Center - Sugar Land
1347
mi
from 91732
Sugar Land, TX
Click here to add this to my saved trials
TAC Versus TC for Adjuvant Breast Cancer
Phase III Trial of TC Versus TAC in HER2-Negative Early Stage Breast Cancer Patients
Status: Enrolling
Updated:  12/31/1969
1315
mi
from 91732
Tyler, TX
TAC Versus TC for Adjuvant Breast Cancer
Phase III Trial of TC Versus TAC in HER2-Negative Early Stage Breast Cancer Patients
Status: Enrolling
Updated: 12/31/1969
Tyler Cancer Center
1315
mi
from 91732
Tyler, TX
Click here to add this to my saved trials
TAC Versus TC for Adjuvant Breast Cancer
Phase III Trial of TC Versus TAC in HER2-Negative Early Stage Breast Cancer Patients
Status: Enrolling
Updated:  12/31/1969
1222
mi
from 91732
Waco, TX
TAC Versus TC for Adjuvant Breast Cancer
Phase III Trial of TC Versus TAC in HER2-Negative Early Stage Breast Cancer Patients
Status: Enrolling
Updated: 12/31/1969
Texas Oncology Cancer Care and Research
1222
mi
from 91732
Waco, TX
Click here to add this to my saved trials
TAC Versus TC for Adjuvant Breast Cancer
Phase III Trial of TC Versus TAC in HER2-Negative Early Stage Breast Cancer Patients
Status: Enrolling
Updated:  12/31/1969
1377
mi
from 91732
Webster, TX
TAC Versus TC for Adjuvant Breast Cancer
Phase III Trial of TC Versus TAC in HER2-Negative Early Stage Breast Cancer Patients
Status: Enrolling
Updated: 12/31/1969
Texas Oncology, P.A.
1377
mi
from 91732
Webster, TX
Click here to add this to my saved trials
TAC Versus TC for Adjuvant Breast Cancer
Phase III Trial of TC Versus TAC in HER2-Negative Early Stage Breast Cancer Patients
Status: Enrolling
Updated:  12/31/1969
1113
mi
from 91732
Wichita Falls, TX
TAC Versus TC for Adjuvant Breast Cancer
Phase III Trial of TC Versus TAC in HER2-Negative Early Stage Breast Cancer Patients
Status: Enrolling
Updated: 12/31/1969
Texoma Cancer Center
1113
mi
from 91732
Wichita Falls, TX
Click here to add this to my saved trials
TAC Versus TC for Adjuvant Breast Cancer
Phase III Trial of TC Versus TAC in HER2-Negative Early Stage Breast Cancer Patients
Status: Enrolling
Updated:  12/31/1969
2267
mi
from 91732
Fairfax, VA
TAC Versus TC for Adjuvant Breast Cancer
Phase III Trial of TC Versus TAC in HER2-Negative Early Stage Breast Cancer Patients
Status: Enrolling
Updated: 12/31/1969
Fairfax Northern VA Hem-Onc PC
2267
mi
from 91732
Fairfax, VA
Click here to add this to my saved trials
TAC Versus TC for Adjuvant Breast Cancer
Phase III Trial of TC Versus TAC in HER2-Negative Early Stage Breast Cancer Patients
Status: Enrolling
Updated:  12/31/1969
2341
mi
from 91732
Norfolk, VA
TAC Versus TC for Adjuvant Breast Cancer
Phase III Trial of TC Versus TAC in HER2-Negative Early Stage Breast Cancer Patients
Status: Enrolling
Updated: 12/31/1969
Virginia Oncology Associates
2341
mi
from 91732
Norfolk, VA
Click here to add this to my saved trials
TAC Versus TC for Adjuvant Breast Cancer
Phase III Trial of TC Versus TAC in HER2-Negative Early Stage Breast Cancer Patients
Status: Enrolling
Updated:  12/31/1969
2261
mi
from 91732
Richmond, VA
TAC Versus TC for Adjuvant Breast Cancer
Phase III Trial of TC Versus TAC in HER2-Negative Early Stage Breast Cancer Patients
Status: Enrolling
Updated: 12/31/1969
Virginia Cancer Institute
2261
mi
from 91732
Richmond, VA
Click here to add this to my saved trials
TAC Versus TC for Adjuvant Breast Cancer
Phase III Trial of TC Versus TAC in HER2-Negative Early Stage Breast Cancer Patients
Status: Enrolling
Updated:  12/31/1969
2201
mi
from 91732
Salem, VA
TAC Versus TC for Adjuvant Breast Cancer
Phase III Trial of TC Versus TAC in HER2-Negative Early Stage Breast Cancer Patients
Status: Enrolling
Updated: 12/31/1969
Onc and Hem Associates os SW VA, Inc.
2201
mi
from 91732
Salem, VA
Click here to add this to my saved trials
TAC Versus TC for Adjuvant Breast Cancer
Phase III Trial of TC Versus TAC in HER2-Negative Early Stage Breast Cancer Patients
Status: Enrolling
Updated:  12/31/1969
951
mi
from 91732
Burien, WA
TAC Versus TC for Adjuvant Breast Cancer
Phase III Trial of TC Versus TAC in HER2-Negative Early Stage Breast Cancer Patients
Status: Enrolling
Updated: 12/31/1969
Highline Medical Oncology
951
mi
from 91732
Burien, WA
Click here to add this to my saved trials
TAC Versus TC for Adjuvant Breast Cancer
Phase III Trial of TC Versus TAC in HER2-Negative Early Stage Breast Cancer Patients
Status: Enrolling
Updated:  12/31/1969
975
mi
from 91732
Edmonds, WA
TAC Versus TC for Adjuvant Breast Cancer
Phase III Trial of TC Versus TAC in HER2-Negative Early Stage Breast Cancer Patients
Status: Enrolling
Updated: 12/31/1969
Pudget Sound Cancer Center-Edmonds
975
mi
from 91732
Edmonds, WA
Click here to add this to my saved trials
TAC Versus TC for Adjuvant Breast Cancer
Phase III Trial of TC Versus TAC in HER2-Negative Early Stage Breast Cancer Patients
Status: Enrolling
Updated:  12/31/1969
840
mi
from 91732
Kennewick, WA
TAC Versus TC for Adjuvant Breast Cancer
Phase III Trial of TC Versus TAC in HER2-Negative Early Stage Breast Cancer Patients
Status: Enrolling
Updated: 12/31/1969
Kadlec Hematology & Oncology
840
mi
from 91732
Kennewick, WA
Click here to add this to my saved trials
TAC Versus TC for Adjuvant Breast Cancer
Phase III Trial of TC Versus TAC in HER2-Negative Early Stage Breast Cancer Patients
Status: Enrolling
Updated:  12/31/1969
970
mi
from 91732
Seattle, WA
TAC Versus TC for Adjuvant Breast Cancer
Phase III Trial of TC Versus TAC in HER2-Negative Early Stage Breast Cancer Patients
Status: Enrolling
Updated: 12/31/1969
Puget Sound Cancer Center - Seattle
970
mi
from 91732
Seattle, WA
Click here to add this to my saved trials
TAC Versus TC for Adjuvant Breast Cancer
Phase III Trial of TC Versus TAC in HER2-Negative Early Stage Breast Cancer Patients
Status: Enrolling
Updated:  12/31/1969
939
mi
from 91732
Spokane, WA
TAC Versus TC for Adjuvant Breast Cancer
Phase III Trial of TC Versus TAC in HER2-Negative Early Stage Breast Cancer Patients
Status: Enrolling
Updated: 12/31/1969
Cancer Care Northwest-South
939
mi
from 91732
Spokane, WA
Click here to add this to my saved trials
TAC Versus TC for Adjuvant Breast Cancer
Phase III Trial of TC Versus TAC in HER2-Negative Early Stage Breast Cancer Patients
Status: Enrolling
Updated:  12/31/1969
835
mi
from 91732
Vancouver, WA
TAC Versus TC for Adjuvant Breast Cancer
Phase III Trial of TC Versus TAC in HER2-Negative Early Stage Breast Cancer Patients
Status: Enrolling
Updated: 12/31/1969
Northwest Cancer Specialists-Vancouver
835
mi
from 91732
Vancouver, WA
Click here to add this to my saved trials
TAC Versus TC for Adjuvant Breast Cancer
Phase III Trial of TC Versus TAC in HER2-Negative Early Stage Breast Cancer Patients
Status: Enrolling
Updated:  12/31/1969
875
mi
from 91732
Yakima, WA
TAC Versus TC for Adjuvant Breast Cancer
Phase III Trial of TC Versus TAC in HER2-Negative Early Stage Breast Cancer Patients
Status: Enrolling
Updated: 12/31/1969
Yakima Valley Mem Hosp/North Star Lodge
875
mi
from 91732
Yakima, WA
Click here to add this to my saved trials
TAC Versus TC for Adjuvant Breast Cancer
Phase III Trial of TC Versus TAC in HER2-Negative Early Stage Breast Cancer Patients
Status: Enrolling
Updated:  12/31/1969
875
mi
from 91732
Yakima, WA
TAC Versus TC for Adjuvant Breast Cancer
Phase III Trial of TC Versus TAC in HER2-Negative Early Stage Breast Cancer Patients
Status: Enrolling
Updated: 12/31/1969
Yakima Valley Memorial Hospital/North Star Lodge
875
mi
from 91732
Yakima, WA
Click here to add this to my saved trials
TAC Versus TC for Adjuvant Breast Cancer
Phase III Trial of TC Versus TAC in HER2-Negative Early Stage Breast Cancer Patients
Status: Enrolling
Updated:  12/31/1969
2062
mi
from 91732
Beckley, WV
TAC Versus TC for Adjuvant Breast Cancer
Phase III Trial of TC Versus TAC in HER2-Negative Early Stage Breast Cancer Patients
Status: Enrolling
Updated: 12/31/1969
Raleigh Regional Cancer Center
2062
mi
from 91732
Beckley, WV
Click here to add this to my saved trials
TAC Versus TC for Adjuvant Breast Cancer
Phase III Trial of TC Versus TAC in HER2-Negative Early Stage Breast Cancer Patients
Status: Enrolling
Updated:  12/31/1969
1573
mi
from 91732
Saint Louis, MO
TAC Versus TC for Adjuvant Breast Cancer
Phase III Trial of TC Versus TAC in HER2-Negative Early Stage Breast Cancer Patients
Status: Enrolling
Updated: 12/31/1969
Arch Medical Services
1573
mi
from 91732
Saint Louis, MO
Click here to add this to my saved trials
Study to Assess the Efficacy and Safety of a PARP Inhibitor for the Treatment of BRCA-positive Advanced Breast Cancer
A Phase II Open-label, Non-comparative, International, Multicentre Study to Assess the Efficacy and Safety of KU 0059436 (Olaparib) Given Orally Twice Daily in Patients With Advanced BRCA1 or BRCA2 Associated Breast Cancer
Status: Enrolling
Updated:  12/31/1969
13
mi
from 91732
Los Angeles, CA
Study to Assess the Efficacy and Safety of a PARP Inhibitor for the Treatment of BRCA-positive Advanced Breast Cancer
A Phase II Open-label, Non-comparative, International, Multicentre Study to Assess the Efficacy and Safety of KU 0059436 (Olaparib) Given Orally Twice Daily in Patients With Advanced BRCA1 or BRCA2 Associated Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
13
mi
from 91732
Los Angeles, CA
Click here to add this to my saved trials
Study to Assess the Efficacy and Safety of a PARP Inhibitor for the Treatment of BRCA-positive Advanced Breast Cancer
A Phase II Open-label, Non-comparative, International, Multicentre Study to Assess the Efficacy and Safety of KU 0059436 (Olaparib) Given Orally Twice Daily in Patients With Advanced BRCA1 or BRCA2 Associated Breast Cancer
Status: Enrolling
Updated:  12/31/1969
2578
mi
from 91732
Boston, MA
Study to Assess the Efficacy and Safety of a PARP Inhibitor for the Treatment of BRCA-positive Advanced Breast Cancer
A Phase II Open-label, Non-comparative, International, Multicentre Study to Assess the Efficacy and Safety of KU 0059436 (Olaparib) Given Orally Twice Daily in Patients With Advanced BRCA1 or BRCA2 Associated Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2578
mi
from 91732
Boston, MA
Click here to add this to my saved trials
Study to Assess the Efficacy and Safety of a PARP Inhibitor for the Treatment of BRCA-positive Advanced Breast Cancer
A Phase II Open-label, Non-comparative, International, Multicentre Study to Assess the Efficacy and Safety of KU 0059436 (Olaparib) Given Orally Twice Daily in Patients With Advanced BRCA1 or BRCA2 Associated Breast Cancer
Status: Enrolling
Updated:  12/31/1969
2435
mi
from 91732
New York, NY
Study to Assess the Efficacy and Safety of a PARP Inhibitor for the Treatment of BRCA-positive Advanced Breast Cancer
A Phase II Open-label, Non-comparative, International, Multicentre Study to Assess the Efficacy and Safety of KU 0059436 (Olaparib) Given Orally Twice Daily in Patients With Advanced BRCA1 or BRCA2 Associated Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2435
mi
from 91732
New York, NY
Click here to add this to my saved trials
Study to Assess the Efficacy and Safety of a PARP Inhibitor for the Treatment of BRCA-positive Advanced Breast Cancer
A Phase II Open-label, Non-comparative, International, Multicentre Study to Assess the Efficacy and Safety of KU 0059436 (Olaparib) Given Orally Twice Daily in Patients With Advanced BRCA1 or BRCA2 Associated Breast Cancer
Status: Enrolling
Updated:  12/31/1969
2375
mi
from 91732
Philadelphia, PA
Study to Assess the Efficacy and Safety of a PARP Inhibitor for the Treatment of BRCA-positive Advanced Breast Cancer
A Phase II Open-label, Non-comparative, International, Multicentre Study to Assess the Efficacy and Safety of KU 0059436 (Olaparib) Given Orally Twice Daily in Patients With Advanced BRCA1 or BRCA2 Associated Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
2375
mi
from 91732
Philadelphia, PA
Click here to add this to my saved trials
Study to Assess the Efficacy and Safety of a PARP Inhibitor for the Treatment of BRCA-positive Advanced Breast Cancer
A Phase II Open-label, Non-comparative, International, Multicentre Study to Assess the Efficacy and Safety of KU 0059436 (Olaparib) Given Orally Twice Daily in Patients With Advanced BRCA1 or BRCA2 Associated Breast Cancer
Status: Enrolling
Updated:  12/31/1969
1225
mi
from 91732
Dallas, TX
Study to Assess the Efficacy and Safety of a PARP Inhibitor for the Treatment of BRCA-positive Advanced Breast Cancer
A Phase II Open-label, Non-comparative, International, Multicentre Study to Assess the Efficacy and Safety of KU 0059436 (Olaparib) Given Orally Twice Daily in Patients With Advanced BRCA1 or BRCA2 Associated Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
1225
mi
from 91732
Dallas, TX
Click here to add this to my saved trials
Study to Assess the Efficacy and Safety of a PARP Inhibitor for the Treatment of BRCA-positive Advanced Breast Cancer
A Phase II Open-label, Non-comparative, International, Multicentre Study to Assess the Efficacy and Safety of KU 0059436 (Olaparib) Given Orally Twice Daily in Patients With Advanced BRCA1 or BRCA2 Associated Breast Cancer
Status: Enrolling
Updated:  12/31/1969
7949
mi
from 91732
Melbourne,
Study to Assess the Efficacy and Safety of a PARP Inhibitor for the Treatment of BRCA-positive Advanced Breast Cancer
A Phase II Open-label, Non-comparative, International, Multicentre Study to Assess the Efficacy and Safety of KU 0059436 (Olaparib) Given Orally Twice Daily in Patients With Advanced BRCA1 or BRCA2 Associated Breast Cancer
Status: Enrolling
Updated: 12/31/1969
Research Site
7949
mi
from 91732
Melbourne,
Click here to add this to my saved trials
Weight Gain Prevention for Breast Cancer Survivors
Weight Gain Prevention for Breast Cancer Survivors
Status: Enrolling
Updated:  12/31/1969
1357
mi
from 91732
Houston, TX
Weight Gain Prevention for Breast Cancer Survivors
Weight Gain Prevention for Breast Cancer Survivors
Status: Enrolling
Updated: 12/31/1969
University of Texas M.D. Anderson Cancer Center
1357
mi
from 91732
Houston, TX
Click here to add this to my saved trials
Meditation and Cognitive Function in Women With Breast Cancer
Feasibility Study of Meditation, Cognitive Function, and Quality of Life in Women With Breast Cancer
Status: Enrolling
Updated:  12/31/1969
1357
mi
from 91732
Houston, TX
Meditation and Cognitive Function in Women With Breast Cancer
Feasibility Study of Meditation, Cognitive Function, and Quality of Life in Women With Breast Cancer
Status: Enrolling
Updated: 12/31/1969
University of Texas M.D. Anderson Cancer Center
1357
mi
from 91732
Houston, TX
Click here to add this to my saved trials
Randomized, Double Blind Multicenter Phase II Study of Time to Progression on Fulvestrant in Combination With Erlotinib or Placebo in Hormone Receptor-Positive Metastatic Breast Cancer (MBC) Subjects Who Progressed on First Line Hormonal Therapy
Randomized, Double Blind Multicenter Phase II Study of Time to Progression on Fulvestrant in Combination With Erlotinib or Placebo in Hormone Receptor-Positive Metastatic Breast Cancer (MBC) Subjects Who Progressed on First Line Hormonal Therapy
Status: Enrolling
Updated:  12/31/1969
1549
mi
from 91732
Jonesboro, AR
Randomized, Double Blind Multicenter Phase II Study of Time to Progression on Fulvestrant in Combination With Erlotinib or Placebo in Hormone Receptor-Positive Metastatic Breast Cancer (MBC) Subjects Who Progressed on First Line Hormonal Therapy
Randomized, Double Blind Multicenter Phase II Study of Time to Progression on Fulvestrant in Combination With Erlotinib or Placebo in Hormone Receptor-Positive Metastatic Breast Cancer (MBC) Subjects Who Progressed on First Line Hormonal Therapy
Status: Enrolling
Updated: 12/31/1969
NEA Clinic
1549
mi
from 91732
Jonesboro, AR
Click here to add this to my saved trials
Randomized, Double Blind Multicenter Phase II Study of Time to Progression on Fulvestrant in Combination With Erlotinib or Placebo in Hormone Receptor-Positive Metastatic Breast Cancer (MBC) Subjects Who Progressed on First Line Hormonal Therapy
Randomized, Double Blind Multicenter Phase II Study of Time to Progression on Fulvestrant in Combination With Erlotinib or Placebo in Hormone Receptor-Positive Metastatic Breast Cancer (MBC) Subjects Who Progressed on First Line Hormonal Therapy
Status: Enrolling
Updated:  12/31/1969
1461
mi
from 91732
Little Rock, AR
Randomized, Double Blind Multicenter Phase II Study of Time to Progression on Fulvestrant in Combination With Erlotinib or Placebo in Hormone Receptor-Positive Metastatic Breast Cancer (MBC) Subjects Who Progressed on First Line Hormonal Therapy
Randomized, Double Blind Multicenter Phase II Study of Time to Progression on Fulvestrant in Combination With Erlotinib or Placebo in Hormone Receptor-Positive Metastatic Breast Cancer (MBC) Subjects Who Progressed on First Line Hormonal Therapy
Status: Enrolling
Updated: 12/31/1969
University of Arkansas for Medical Sciences
1461
mi
from 91732
Little Rock, AR
Click here to add this to my saved trials
Randomized, Double Blind Multicenter Phase II Study of Time to Progression on Fulvestrant in Combination With Erlotinib or Placebo in Hormone Receptor-Positive Metastatic Breast Cancer (MBC) Subjects Who Progressed on First Line Hormonal Therapy
Randomized, Double Blind Multicenter Phase II Study of Time to Progression on Fulvestrant in Combination With Erlotinib or Placebo in Hormone Receptor-Positive Metastatic Breast Cancer (MBC) Subjects Who Progressed on First Line Hormonal Therapy
Status: Enrolling
Updated:  12/31/1969
1355
mi
from 91732
Springdale, AR
Randomized, Double Blind Multicenter Phase II Study of Time to Progression on Fulvestrant in Combination With Erlotinib or Placebo in Hormone Receptor-Positive Metastatic Breast Cancer (MBC) Subjects Who Progressed on First Line Hormonal Therapy
Randomized, Double Blind Multicenter Phase II Study of Time to Progression on Fulvestrant in Combination With Erlotinib or Placebo in Hormone Receptor-Positive Metastatic Breast Cancer (MBC) Subjects Who Progressed on First Line Hormonal Therapy
Status: Enrolling
Updated: 12/31/1969
Highlands Oncology Group
1355
mi
from 91732
Springdale, AR
Click here to add this to my saved trials
Randomized, Double Blind Multicenter Phase II Study of Time to Progression on Fulvestrant in Combination With Erlotinib or Placebo in Hormone Receptor-Positive Metastatic Breast Cancer (MBC) Subjects Who Progressed on First Line Hormonal Therapy
Randomized, Double Blind Multicenter Phase II Study of Time to Progression on Fulvestrant in Combination With Erlotinib or Placebo in Hormone Receptor-Positive Metastatic Breast Cancer (MBC) Subjects Who Progressed on First Line Hormonal Therapy
Status: Enrolling
Updated:  12/31/1969
1919
mi
from 91732
Atlanta, GA
Randomized, Double Blind Multicenter Phase II Study of Time to Progression on Fulvestrant in Combination With Erlotinib or Placebo in Hormone Receptor-Positive Metastatic Breast Cancer (MBC) Subjects Who Progressed on First Line Hormonal Therapy
Randomized, Double Blind Multicenter Phase II Study of Time to Progression on Fulvestrant in Combination With Erlotinib or Placebo in Hormone Receptor-Positive Metastatic Breast Cancer (MBC) Subjects Who Progressed on First Line Hormonal Therapy
Status: Enrolling
Updated: 12/31/1969
Emory University
1919
mi
from 91732
Atlanta, GA
Click here to add this to my saved trials
Randomized, Double Blind Multicenter Phase II Study of Time to Progression on Fulvestrant in Combination With Erlotinib or Placebo in Hormone Receptor-Positive Metastatic Breast Cancer (MBC) Subjects Who Progressed on First Line Hormonal Therapy
Randomized, Double Blind Multicenter Phase II Study of Time to Progression on Fulvestrant in Combination With Erlotinib or Placebo in Hormone Receptor-Positive Metastatic Breast Cancer (MBC) Subjects Who Progressed on First Line Hormonal Therapy
Status: Enrolling
Updated:  12/31/1969
1341
mi
from 91732
Kansas City, MO
Randomized, Double Blind Multicenter Phase II Study of Time to Progression on Fulvestrant in Combination With Erlotinib or Placebo in Hormone Receptor-Positive Metastatic Breast Cancer (MBC) Subjects Who Progressed on First Line Hormonal Therapy
Randomized, Double Blind Multicenter Phase II Study of Time to Progression on Fulvestrant in Combination With Erlotinib or Placebo in Hormone Receptor-Positive Metastatic Breast Cancer (MBC) Subjects Who Progressed on First Line Hormonal Therapy
Status: Enrolling
Updated: 12/31/1969
St. Luke'S Cancer Institute
1341
mi
from 91732
Kansas City, MO
Click here to add this to my saved trials
Randomized, Double Blind Multicenter Phase II Study of Time to Progression on Fulvestrant in Combination With Erlotinib or Placebo in Hormone Receptor-Positive Metastatic Breast Cancer (MBC) Subjects Who Progressed on First Line Hormonal Therapy
Randomized, Double Blind Multicenter Phase II Study of Time to Progression on Fulvestrant in Combination With Erlotinib or Placebo in Hormone Receptor-Positive Metastatic Breast Cancer (MBC) Subjects Who Progressed on First Line Hormonal Therapy
Status: Enrolling
Updated:  12/31/1969
2430
mi
from 91732
Hackensack, NJ
Randomized, Double Blind Multicenter Phase II Study of Time to Progression on Fulvestrant in Combination With Erlotinib or Placebo in Hormone Receptor-Positive Metastatic Breast Cancer (MBC) Subjects Who Progressed on First Line Hormonal Therapy
Randomized, Double Blind Multicenter Phase II Study of Time to Progression on Fulvestrant in Combination With Erlotinib or Placebo in Hormone Receptor-Positive Metastatic Breast Cancer (MBC) Subjects Who Progressed on First Line Hormonal Therapy
Status: Enrolling
Updated: 12/31/1969
Hackensack University
2430
mi
from 91732
Hackensack, NJ
Click here to add this to my saved trials